496 related articles for article (PubMed ID: 23954771)
41. Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis.
Zhou Y; Yin X; Ying J; Zhang B
BMC Cancer; 2012 Jan; 12():17. PubMed ID: 22244200
[TBL] [Abstract][Full Text] [Related]
42. Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein.
Oka H; Saito A; Ito K; Kumada T; Satomura S; Kasugai H; Osaki Y; Seki T; Kudo M; Tanaka M;
J Gastroenterol Hepatol; 2001 Dec; 16(12):1378-83. PubMed ID: 11851836
[TBL] [Abstract][Full Text] [Related]
43. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.
Zhao Y; Wang M; Cui C; Zhang L; Liao F; Li H; Wu X
Cancer Biomark; 2015; 15(5):677-83. PubMed ID: 26406957
[TBL] [Abstract][Full Text] [Related]
44. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
45. Differential lectin reactivities of alpha-fetoprotein in hepatocellular carcinoma: diagnostic value when serum alpha-fetoprotein levels are slightly raised.
van Staden L; Bukofzer S; Kew MC; Savage N
J Gastroenterol Hepatol; 1992; 7(3):260-5. PubMed ID: 1377039
[TBL] [Abstract][Full Text] [Related]
46. Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3.
Volk ML; Hernandez JC; Su GL; Lok AS; Marrero JA
Cancer Biomark; 2007; 3(2):79-87. PubMed ID: 17522429
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation.
Nörthen A; Asendorf T; Walson PD; Oellerich M
Clin Biochem; 2018 Feb; 52():20-25. PubMed ID: 29054441
[TBL] [Abstract][Full Text] [Related]
48. High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma.
Kumada T; Toyoda H; Tada T; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Tanaka J; Kagebayashi C; Satomura S
J Gastroenterol; 2014 Mar; 49(3):555-63. PubMed ID: 24057163
[TBL] [Abstract][Full Text] [Related]
49. Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis.
Kumada T; Nakano S; Takeda I; Kiriyama S; Sone Y; Hayashi K; Katoh H; Endoh T; Sassa T; Satomura S
J Hepatol; 1999 Jan; 30(1):125-30. PubMed ID: 9927159
[TBL] [Abstract][Full Text] [Related]
50. Clinical Assay for AFP-L3 by Using Multiple Reaction Monitoring-Mass Spectrometry for Diagnosing Hepatocellular Carcinoma.
Kim H; Sohn A; Yeo I; Yu SJ; Yoon JH; Kim Y
Clin Chem; 2018 Aug; 64(8):1230-1238. PubMed ID: 29875214
[TBL] [Abstract][Full Text] [Related]
51. Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis.
Sterling RK; Jeffers L; Gordon F; Sherman M; Venook AP; Reddy KR; Satomura S; Schwartz ME
Am J Gastroenterol; 2007 Oct; 102(10):2196-205. PubMed ID: 17617202
[TBL] [Abstract][Full Text] [Related]
52. Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma.
Khien VV; Mao HV; Chinh TT; Ha PT; Bang MH; Lac BV; Hop TV; Tuan NA; Don LV; Taketa K; Satomura S
Int J Biol Markers; 2001; 16(2):105-11. PubMed ID: 11471892
[TBL] [Abstract][Full Text] [Related]
53. Highly sensitive Lens culinaris agglutinin-reactive α-fetoprotein: a new tool for the management of hepatocellular carcinoma.
Toyoda H; Kumada T; Tada T
Oncology; 2011; 81 Suppl 1():61-5. PubMed ID: 22212938
[TBL] [Abstract][Full Text] [Related]
54. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
Song X; Wu A; Ding Z; Liang S; Zhang C
Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
[TBL] [Abstract][Full Text] [Related]
55. Clinical significance of lens culinaris agglutinin-reactive fraction of serum alpha-fetoprotein in patients with hepatocellular carcinoma.
Yoshida S; Kurokohchi K; Arima K; Masaki T; Hosomi N; Funaki T; Murota M; Kita Y; Watanabe S; Kuriyama S
Int J Oncol; 2002 Feb; 20(2):305-9. PubMed ID: 11788893
[TBL] [Abstract][Full Text] [Related]
56. Comparison of AFP-L3 and p53 Antigen Concentration with Alpha-Fetoprotein as Serum Markers for Hepatocellular Carcinoma.
Abdel-Aziz MM; Elshal MF; Abass AT; El-Kafrawy S; Ezzat S; Abdel-Wahab M
Clin Lab; 2016; 62(6):1121-9. PubMed ID: 27468575
[TBL] [Abstract][Full Text] [Related]
57. Comparison osteopontin vs AFP for the diagnosis of HCC: a meta-analysis.
Wan HG; Xu H; Gu YM; Wang H; Xu W; Zu MH
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):706-14. PubMed ID: 25034355
[TBL] [Abstract][Full Text] [Related]
58. Prognostic role of pre-treatment serum AFP-L3% in hepatocellular carcinoma: systematic review and meta-analysis.
Cheng J; Wang W; Zhang Y; Liu X; Li M; Wu Z; Liu Z; Lv Y; Wang B
PLoS One; 2014; 9(1):e87011. PubMed ID: 24498011
[TBL] [Abstract][Full Text] [Related]
59. Electrochemical Assay of the Alpha Fetoprotein-L3 Isoform Ratio To Improve the Diagnostic Accuracy of Hepatocellular Carcinoma.
Wei T; Zhang W; Tan Q; Cui X; Dai Z
Anal Chem; 2018 Nov; 90(21):13051-13058. PubMed ID: 30350622
[TBL] [Abstract][Full Text] [Related]
60. Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas.
Yamashita F; Tanaka M; Satomura S; Tanikawa K
Gastroenterology; 1996 Oct; 111(4):996-1001. PubMed ID: 8831594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
